|
|
Volumn 19, Issue 2, 2008, Pages 49-50
|
|
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
PROTEINASE;
RNA DIRECTED DNA POLYMERASE;
VIRUS VACCINE;
'ZOSTER';
1O HEXADECYLOXYPROPYL 1 (3 HYDROXY 2 PHOSPHONYLMETHOXYPROPYL)CYTOSINE;
3 (2' DEOXY BETA DEXTRO RIBOFURANOSYL) 6 (4 N PENTYLPHENYL) 2,3 DIHYDROFURO[2,3D]PYRAMIDIN 2 ONE 5' VALYL ESTER;
4 TRIFLUOROMETHYL N (3,3A,4,4A,5,5A,6,6A OCTAHYDRO 1,3 DIOXO 4,6 ETHENOCYCLOPROP[F]ISOINDOL 2(H) YL)BENZAMIDE;
5 (2 BROMOVINYL) 2' DEOXYURIDINE;
ACICLOVIR;
ADEFOVIR DIPIVOXIL;
BAY 57 1293;
BENZIMIDAVIR;
BRIVIRAC;
CIDOFOVIR;
CLEVUDINE;
FAMCICLOVIR;
FIALURIDINE;
FLUOROURACIL;
FOMIVIRSEN;
FOSCARNET;
FOSCARNET SODIUM;
FV 100;
GANCICLOVIR;
HDP CDV;
IDOXURIDINE;
IMIQUIMOD;
PENCICLOVIR;
PRO 2000;
PRO 2000 5;
SORIVUDINE;
ST 246;
TELBIVUDINE;
TRIFLURIDINE;
VALACICLOVIR;
VALGANCICLOVIR;
VALOMACICLOVIR STEARATE;
VIDARABINE;
ZERPEX;
ZOSTEX;
ANTIVIRAL ACTIVITY;
ANTIVIRAL RESISTANCE;
ANTIVIRAL THERAPY;
DNA VIRUS;
DRUG RESEARCH;
DRUG STRUCTURE;
DRUG TARGETING;
EDITORIAL;
HEPADNAVIRUS;
HEPATITIS VIRUS;
HERPES VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS;
PRIORITY JOURNAL;
PUBLICATION;
RETROVIRUS;
RNA VIRUS;
VIRUS MUTATION;
CLINICAL TRIAL;
CYTOMEGALOVIRUS;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG HALF LIFE;
EPSTEIN BARR VIRUS;
FELINE IMMUNODEFICIENCY VIRUS;
HEPATITIS B VIRUS;
HERPES SIMPLEX VIRUS;
HUMAN;
LIVER TOXICITY;
NONHUMAN;
REVIEW;
SIMIAN IMMUNODEFICIENCY VIRUS;
VIRUS INFECTION;
WART VIRUS;
|
|
EID: 50349087340
PISSN: 09563202
EISSN: None
Source Type: Journal
DOI: 10.1177/095632020801900202 Document Type: Editorial |
|
Times cited : (15)
|
|
References (4)
|
